Temporal strength changes from resistance exercise and albuterol on unloaded muscle

Journal of Strength and Conditioning Research

Volumn 22, Issue 4, 2008, Pages 1156-1163

  Caruso, John F ^a   Hamill, John L ^b   Yamauchi, Miki ^b   Saito, Kyoko ^b   Cook, Tim D ^c   Mercado, Dean R ^c  

^a UNIVERSITY OF TULSA   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

Concentric; Eccentric

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERGOMETRY; FEMALE; HUMAN; MALE; MUSCLE STRENGTH; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SKELETAL MUSCLE; WEIGHT BEARING;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; DOUBLE-BLIND METHOD; ERGOMETRY; FEMALE; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; SEX FACTORS; WEIGHT-BEARING;

EID: 51249091995     PISSN: 10648011     EISSN: None     Source Type: Journal    
DOI: 10.1519/JSC.0b013e31816eb46a     Document Type: Article

References (40)

1. Alkner, BA and Tesch, PA. Knee extensor and plantar flexor muscle size and function following 90 days of bed rest with or without resistance exercise. Eur J Appl Physiol 93: 294-305, 2004.
2. Banerjee, SP, Sharma, VK, and Kung, LS. b-adrenergic receptors in innervated and denervated skeletal muscles. Biochim Biophys Acta 470: 123-127, 1977.
3. Bangart, JJ, Widrick, JJ, and Fitts, RH. Effect of intermittent weight bearing on soleus fiber force-velocity-power and force-pCa relationships. J Appl Physiol 82: 1905-1910, 1997.
4. Berg, HE and Tesch, PA. Changes in muscle function in response to 10 days of lower limb unloading in humans. Acta Physiol Scand 157: 63-70, 1996.
5. Bleeker, MWP, Hopman, MTE, Rogers, GA, and Smits, P. Unilateral lower limb suspension can cause deep venous thrombosis. Am J Physiol Regul Integr Comp Physiol 286: R1176-R1177, 2004.
6. Bremner, P, Siebers, R, Crane, J, Beasley, R, and Burgess, C. Partial vs full b-receptor agonism: a clinical study of inhaled albuterol and fenoterol. Chest 109: 957-962, 1996.
7. 2+]i during beta-adrenoceptor activation of single, intact fibers from mouse skeletal muscle. Pflugers Arch 425: 150-155, 1993.
8. Caruso, JF, Hamill, JL, Yamauchi, M, Cook, TD, Mercado, DR, Gibb, G, Higginson, B, Elias, J, and Hernandez, DA. Can albuterol help resistance exercise attenuate unloading-induced bone losses? J Strength Cond Res 18: 753-759, 2004.
9. Caruso, JF, Hamill, JL, Yamauchi, M, Mercado, DR, Cook, TD, Kelller, CP, Montgomery, AG, and Elias, J. Albuterol helps resistance exercise attenuate unloading-induced knee extensor losses. Aviat Space Environ Med 75: 505-511, 2004.
10. 2 agonist administration. J Strength Cond Res 11: 8-13, 1997.
11. Caruso, JF, Signorile, JF, Perry, AC, Clark, M, Leblanc, B, Williams, R, and Bamman, MM. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 27:1471-1476, 1995.
12. Chen, KD and Alway, SE. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats. J Appl Physiol 89: 606-612, 2000.
13. Choo, JJ, Horan, MA, Little, RA, and Rothwell, NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by b2-adrenoreceptor activation. Am J Physiol 263: E50-E56, 1992.
14. Clarke, MSF, Caldwell, RW, and Feeback, DL. Modulation of sarcoplasmic reticulum cholesterol content during mechanical unloading-induced muscle atrophy. In: 13th IAA Humans in Space Symposium. Greek Aerospace Medical Association, eds. Santorini, Greece, 2000. pp. 22-30.
15. Convertino, VA, Polet, JL, Engelke, KA, Hoffler, GW, Lane, LD, and Blomqvist, CG. Evidence for increased β-adrenoceptor responsiveness induced by 14 days of simulated microgravity in humans. Am J Physiol 373: R93-R99, 1997.
16. Cullum, VA, Farmer, JB, Jack, D, and Levy, GP. Salbutamol: a new, selective β-adrenoreceptive receptor stimulant. Br J Pharmacol 35: 141-151, 1969.
17. Dudley, GA, Duvosin, MR, Adams, GR, Meyer, RA, Belew, AH, and Buchanan, P. Adaptations to unilateral lower limb suspension in humans. Aviat Space Environ Med 63: 678-683, 1992.
18. Duncan, ND, Williams, DA, and Lynch, GS. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clin Sci 98: 339-347, 2000.
19. Edgerton, VR, Zhou, M-Y, Ohira, Y, Klitgaard, H, Jiang, B, Bell, G, Harris, B, Saltin, B, Gollnick, PD, Roy, RR, Day, MK, and Greenisen, M. Human fiber size and enzymatic properties after 5 and 11 days of space flight. J Appl Physiol 78: 1733-1739, 1995.
20. Fitts, RH, Riley, DR, and Widrick, JJ. Physiology of a microgravity environment invited review: microgravity and skeletal muscle. J Appl Physiol 89: 823-839, 2000.
21. Greenleaf, JE, Bulbulian, R, Bernauer, EM, Haskell, WL, and Moore, T. Exercise-training protocols for astronauts in microgravity. J Appl Physiol 67: 2191-2204, 1989.
22. Haddad, F, Adams, GR, Bodell, PW, and Baldwin, KM. Isometric resistance exercise fails to counteract skeletal muscle atrophy process during the initial stages of unloading. J Appl Physiol 100: 433-441, 2006.
23. Keppel, G, Saufley, WH, and Tokunaga, H. Introduction to Design and Analysis (2nd ed.). New York: W.H. Freeman and Company, 1992.
24. Kissel JT, McDermott, MP, Mendell, JR, King, WM, Pandya, S, Griggs, RC, and Tawil, R. Randomized double-blind placebo controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57: 1434-1440, 2001.
25. Larsson, S and Svedmyr, N. Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors. Scand J Resp Dis 58: 5-10, 1977.
26. 2-agonist administration and exercise on contractile elevation of skeletal muscle fibers. J Appl Physiol 81: 1610-1618, 1996.
27. Maltin, CA, Delday, MI, Hay, SM, and Baillie, AGS. Denervation increases clenbuterol sensitivity in muscle from young rats. Muscle Nerve 15: 188-192, 1992.
28. Maltin, CA, Delday, MI, Watson, JS, Heys, SD, Nevison, IM, Ritchie, IK, and Gibson, PH. Clenbuterol, a b-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci 84: 651-654, 1993.
29. 2-adrenergic agonist, increases skeletal muscle strength in young men. Clin Sci83: 615-621, 1992.
30. Morgan, DJ. Clinical pharmokinetics of β-agonists. Clin Pharmokinet 18: 270-294, 1990.
31. 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 63:26-31, 1985.
32. 2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am J Physiol Cell Physiol 278: C582-C588, 2000.
33. Riley, DA. Is skeletal muscle ready for long-term spaceflight and return to gravity? Adv Space Biol Med 7: 31-48, 1999.
34. 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol 283: R1386-R1394, 2002.
35. Sarwar, R, Beltran-Nicols, B, and Rutherford, OM. Changes in muscle strength, relaxation rate, and fatigability during the human menstrual cycle. J Physiol 493: 267-272, 1996.
36. Schulze, K, Gallagher, P, and Trappe, S. Resistance training preserves skeletal muscle function during unloading in humans. Med Sci Sports Exerc34: 303-313, 2002.
37. Shapland, JE, Garner, HE, and Hatfield, DG. Cardiopulmonary effects of clenbuterol in the horse. J Vet Pharmacol Ther 4: 43-50, 1981.
38. Tesch, PA, Trieschmann, JT, and Ekberg, A. Hypertrophy of chronically unloaded muscle subjected to resistance exercise. J Appl Physiol 96: 1451-1458, 2004.
39. Thornton, WE and Rummel, JA. Muscular deconditioning and its prevention in space flight. In: Biomedical Results From Skylab. R.S. Johnston and L.F. Dietlein, eds. Washington, DC: 1977. pp. 191-197.
40. Widrick, JJ, Norenberg, KM, Romatowski, JG, Blaser, CA, Karhanek, M, Sherwood, J, Trappe, SW, Trappe, TA, Costill, DL, and Fitts, RH. Force-velocity and force-pCa relationships of human soleus fibers after 17 days of bed rest. J Appl Physiol 85: 1949-1956, 1998.